Literature DB >> 12149328

Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients.

Mario Anthony1, Barbara Rose, Mary Beard Pegler, Mark Elkins, Helen Service, Keerthi Thamotharampillai, Jason Watson, Michael Robinson, Peter Bye, John Merlino, Colin Harbour.   

Abstract

Genetic investigations were carried out with 50 phenotypically selected strains of Pseudomonas aeruginosa from 18 patients attending an Australian cystic fibrosis (CF) center. The isolates were analyzed by restriction fragment length polymorphism (RFLP) analysis by pulsed-field gel electrophoresis (PFGE). Phylogenetic analysis of the macrorestriction patterns showed rates of genetic similarity ranging from 76 to 100%; 24 (48%) of the strains from 11 patients had greater than 90% similarity. A dominant strain emerged: 15 isolates from seven patients had identical PFGE patterns, and 4 other isolates were very closely related. The 50 isolates were grouped into 21 pulsotypes on the basis of visual delineation of a three-band difference. Ten of the 18 (56%) patients were infected with clonal or subclonal strains. Sequence analysis of PCR products derived from the mucA gene showed 20 mutations, with the number of mutations in individual isolates ranging from 1 to 4; 19 of these changes are reported here for the first time. Potentially functional changes were found in 22 (44%) isolates. Eight changes (five transversions and three single base deletions) led to premature stop codons, providing support for the presence of mucA mutations as one pathway to mucoidy. There was a trend toward an association between the dominant strain and lack of potentially functional mucA mutations (P = 0.09 by the chi(2) test) but no relationship between genotype and phenotype. This is the first study of genetic variation in P. aeruginosa isolates from adult Australian CF patients. The findings highlight the need for further investigations on the transmissibility of P. aeruginosa in CF patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149328      PMCID: PMC120616          DOI: 10.1128/JCM.40.8.2772-2778.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  New approaches in genome analysis by pulsed-field gel electrophoresis: application to the analysis of Pseudomonas species.

Authors:  D Grothues; B Tümmler
Journal:  Mol Microbiol       Date:  1991-11       Impact factor: 3.501

2.  Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients.

Authors:  S Silbert; A L Barth; H S Sader
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

3.  Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa.

Authors:  S J McCallum; J Corkill; M Gallagher; M J Ledson; C A Hart; M J Walshaw
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

4.  Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.

Authors:  A M Jones; J R Govan; C J Doherty; M E Dodd; B J Isalska; T N Stanbridge; A K Webb
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

5.  High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

Authors:  A Oliver; R Cantón; P Campo; F Baquero; J Blázquez
Journal:  Science       Date:  2000-05-19       Impact factor: 47.728

6.  The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants.

Authors:  Antonio Oliver; Fernando Baquero; Jesús Blázquez
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

7.  Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung.

Authors:  Kalai Mathee; Oana Ciofu; Claus Sternberg; Peter W Lindum; Joan I A Campbell; Per Jensen; Anders H Johnsen; Michael Givskov; Dennis E Ohman; Molin Søren; Niels Høiby; Arsalan Kharazmi
Journal:  Microbiology       Date:  1999-06       Impact factor: 2.777

8.  Prevalence and distribution of human papillomavirus type-16 DNA in pelvic lymph nodes of patients with cervical cancer and in women with no history of cervical abnormality.

Authors:  B R Rose; C H Thompson; L A Chantrill; M H Tattersall; Y E Cossart
Journal:  Int J Cancer       Date:  1992-09-09       Impact factor: 7.396

9.  Pulsed-field gel electrophoresis analysis of a Pseudomonas aeruginosa pathovar.

Authors:  U Römling; D Grothues; U Koopmann; B Jahnke; J Greipel; B Tümmler
Journal:  Electrophoresis       Date:  1992 Sep-Oct       Impact factor: 3.535

10.  Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains.

Authors:  D Grothues; U Koopmann; H von der Hardt; B Tümmler
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

View more
  28 in total

1.  Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.

Authors:  Ashley E Warren; Carla M Boulianne-Larsen; Christine B Chandler; Kami Chiotti; Evgueny Kroll; Scott R Miller; Francois Taddei; Isabelle Sermet-Gaudelus; Agnes Ferroni; Kathleen McInnerney; Michael J Franklin; Frank Rosenzweig
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

2.  Towards "molecular Esperanto" or the Tower of Babel? (the need for harmonization of techniques for genotyping clinical isolates of Pseudomonas aeruginosa isolated from patients with cystic fibrosis).

Authors:  John E Moore; Colin E Goldsmith; J Stuart Elborn; Philip G Murphy; Peter H Gilligan; Séamus Fanning; Graham Hogg
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

3.  Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics.

Authors:  David Armstrong; Scott Bell; Michael Robinson; Peter Bye; Barbara Rose; Colin Harbour; Crystal Lee; Helen Service; Michael Nissen; Melanie Syrmis; Claire Wainwright
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

4.  Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model.

Authors:  Alessandra Bragonzi; Dieter Worlitzsch; Gerald B Pier; Petra Timpert; Martina Ulrich; Morten Hentzer; Jens Bo Andersen; Michael Givskov; Massimo Conese; Gerd Doring
Journal:  J Infect Dis       Date:  2005-06-24       Impact factor: 5.226

5.  Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis.

Authors:  J Manos; H Hu; B R Rose; C E Wainwright; I B Zablotska; J Cheney; L Turnbull; C B Whitchurch; K Grimwood; C Harmer; S N Anuj; C Harbour
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-07-07       Impact factor: 3.267

6.  Regulated proteolysis controls mucoid conversion in Pseudomonas aeruginosa.

Authors:  Dongru Qiu; Vonya M Eisinger; Donald W Rowen; Hongwei D Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

7.  Simple sequence repeats and mucoid conversion: biased mucA mutagenesis in mismatch repair-deficient Pseudomonas aeruginosa.

Authors:  Alejandro J Moyano; Andrea M Smania
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

8.  A diagnostic PCR assay for the detection of an Australian epidemic strain of Pseudomonas aeruginosa.

Authors:  Heidi L Williams; Lynne Turnbull; Susan J Thomas; Anna Murphy; Tim Stinear; David S Armstrong; Cynthia B Whitchurch
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-07-16       Impact factor: 3.944

9.  Identification of AlgR-regulated genes in Pseudomonas aeruginosa by use of microarray analysis.

Authors:  Stephen E Lizewski; Jill R Schurr; Debra W Jackson; Anders Frisk; Alexander J Carterson; Michael J Schurr
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

10.  Pseudomonas aeruginosa population structure revisited.

Authors:  Jean-Paul Pirnay; Florence Bilocq; Bruno Pot; Pierre Cornelis; Martin Zizi; Johan Van Eldere; Pieter Deschaght; Mario Vaneechoutte; Serge Jennes; Tyrone Pitt; Daniel De Vos
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.